Market Research Logo

Chronic Idiopathic Constipation (CIC) - Market Insights, Epidemiology, and Market Forecast 2028

DelveInsight's “Chronic Idiopathic Constipation (CIC) - Market Insights, Epidemiology and Market Forecast – 2028” report provides the detailed overview of the disease and in depth understanding of historical and forecasted Chronic Idiopathic Constipation (CIC) epidemiology. It highlights the existing treatment patterns, potential upcoming Chronic Idiopathic Constipation (CIC) drugs and also identifies best of the market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2017-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

Study Period: 2017-2028
Chronic Idiopathic Constipation (CIC) Understanding and Treatment Algorithm
The Chronic Idiopathic Constipation (CIC) market report provides the in depth analysis of the disease overview by providing details such as disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. The comprehensive details about treatment algorithms and treatment guidelines for Chronic Idiopathic Constipation (CIC) in the US, Europe, and Japan are also provided in the report.

Chronic Idiopathic Constipation (CIC) Epidemiology
This section provide the insights about historical and current Chronic Idiopathic Constipation (CIC) patient pool and forecasted trend for 7 major markets. It takes in to account the analysis of numerous studies, survey reports as well as KOL’s views which helps to recognize the factors behind the current and forecasted trends, diagnosed and treatable patient pool along with assumptions undertaken.

Chronic Idiopathic Constipation (CIC) Product Profiles & Analysis
This part of the report encloses the detailed analysis of Chronic Idiopathic Constipation (CIC) marketed drugs and Phase III and late Phase II pipeline drugs. It provides the key cross competition which evaluates the drugs on several parameters including, safety & efficacy results, mechanism of action, route, launch dates and designations. This section also covers the market intelligence and tracking of latest happenings, agreements and collaborations, approvals, patent details and other major breakthroughs.

Chronic Idiopathic Constipation (CIC) Market Outlook
The Chronic Idiopathic Constipation (CIC) market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment analyses the market trend of each marketed drug and late-stage pipeline drugs. This is done by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data is presented with relevant tables and graphs to give a clear view of the market at first sight. Chronic Idiopathic Constipation (CIC) Market Share by Therapies

This section focusses on the rate of uptake of the potential drugs recently launched or will be launched in the market during the study period from 2017-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug. This information also helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It provides the comparison of the drugs on the basis of market share and size. This analysis helps in investigating factors important in market uptake and in making financial as well as regulatory decisions.

Chronic Idiopathic Constipation (CIC) Report Insights
• Chronic Idiopathic Constipation (CIC) Patient Population
• Chronic Idiopathic Constipation (CIC) Therapeutic Approaches
• Chronic Idiopathic Constipation (CIC) Pipeline Analysis
• Chronic Idiopathic Constipation (CIC) Market Size and Trends
• Chronic Idiopathic Constipation (CIC) Market Opportunities
• Impact of upcoming Therapies in Chronic Idiopathic Constipation (CIC)

Chronic Idiopathic Constipation (CIC) Report Key Strengths
• Chronic Idiopathic Constipation (CIC) 10 Year Forecast
• Chronic Idiopathic Constipation (CIC) 7MM Coverage
• Chronic Idiopathic Constipation (CIC) Epidemiology Segmentation
• Chronic Idiopathic Constipation (CIC) Drugs Uptake
• Highly Analyzed Chronic Idiopathic Constipation (CIC) Market
• Key Cross Competition

Chronic Idiopathic Constipation (CIC) Report Assessment
• Current Treatment Practices in Chronic Idiopathic Constipation (CIC)
• Chronic Idiopathic Constipation (CIC) Unmet Needs
• Detailed Chronic Idiopathic Constipation (CIC) Pipeline Product Profiles
• Chronic Idiopathic Constipation (CIC) Market Attractiveness
• Chronic Idiopathic Constipation (CIC) Market Drivers and Barriers

Key Benefits
• This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving the Chronic Idiopathic Constipation (CIC) market
• Organize sales and marketing efforts by identifying the best opportunities for Chronic Idiopathic Constipation (CIC) market
• To understand the future market competition in the Chronic Idiopathic Constipation (CIC) market.

*Please Note: The report will take 7-10 business days to complete upon order confirmation*


1. Report Introduction
2. Chronic Idiopathic Constipation (CIC) Market Overview at a Glance
2.1. Market Share Distribution of Chronic Idiopathic Constipation (CIC) in 2017
2.2. Market Share Distribution of Chronic Idiopathic Constipation (CIC) in 2028
3. Disease Background and Overview: Chronic Idiopathic Constipation (CIC)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Chronic Idiopathic Constipation (CIC) in 7MM
4.3. Total Prevalent Patient Population of Chronic Idiopathic Constipation (CIC) in 7MM – By Countries
5. Epidemiology of Chronic Idiopathic Constipation (CIC) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC)
5.1.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) *Indication Specific
5.1.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) *Indication Specific
5.1.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC)
5.1.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC)
5.4.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) *
5.4.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) *
5.4.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC)
5.4.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC)
5.5.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) *
5.5.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) *
5.5.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC)
5.5.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC)
5.6.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) *
5.6.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) *
5.6.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC)
5.6.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC)
5.7.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) *
5.7.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) *
5.7.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC)
5.7.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC)
5.8.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) *
5.8.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) *
5.8.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC)
5.8.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC)
5.9.3. Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) *
5.9.4. Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) *
5.9.5. Diagnosed Cases of the Chronic Idiopathic Constipation (CIC)
5.9.6. Treatable Cases of the Chronic Idiopathic Constipation (CIC)
6. Current Treatment & Medical practices
6.1. Treatment Algorithm
6.2. Treatment Guidelines
7. Unmet Needs of the Chronic Idiopathic Constipation (CIC)
8. Marketed Therapies
8.1. Drug A: Company 1
8.1.1. Drug Description
8.1.2. Mechanism of Action
8.1.3. Regulatory Milestones
8.1.4. Advantages & Disadvantages
8.1.5. Product Profile
8.2. Drug B: Company 2
8.2.1. Drug Description
8.2.2. Mechanism of Action
8.2.3. Regulatory Milestones
8.2.4. Advantages & Disadvantages
8.2.5. Product Profile
9. Pipeline Therapies – At a glance
10. Key Cross Competition
11. Emerging Therapies for Chronic Idiopathic Constipation (CIC)
11.1. Drug C: Company 3
11.1.1. Drug Description
11.1.2. Clinical Trials Details
11.1.3. Safety and Efficacy Profile
11.1.4. Advantages & Disadvantages
11.1.5. Pipeline Development Activities
11.1.6. Product Profile
11.2. Drug D: Company 4
11.2.1. Drug Description
11.2.2. Clinical Trials Details
11.2.3. Safety and Efficacy Profile
11.2.4. Advantages & Disadvantages
11.2.5. Pipeline Development Activities
11.2.6. Product Profile
12. Chronic Idiopathic Constipation (CIC) : 7MM Market Analysis
12.1. 7MM Market Size of Chronic Idiopathic Constipation (CIC)
12.2. 7MM Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC)
12.3. 7MM Market Sales of Chronic Idiopathic Constipation (CIC) by Products
13. Chronic Idiopathic Constipation (CIC) : Country-Wise Market Analysis
13.1. United States
13.1.1. Market Size of Chronic Idiopathic Constipation (CIC) in United States
13.1.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in United States
13.1.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in United States
13.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2. EU-5
13.2.1. Germany
13.2.1.1. Market Size of Chronic Idiopathic Constipation (CIC) in Germany
13.2.1.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in Germany
13.2.1.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in Germany
13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.2. France
13.2.2.1. Market Size of Chronic Idiopathic Constipation (CIC) in France
13.2.2.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in France
13.2.2.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in France
13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.3. Italy
13.2.3.1. Market Size of Chronic Idiopathic Constipation (CIC) in Italy
13.2.3.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in Italy
13.2.3.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in Italy
13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.4. Spain
13.2.4.1. Market Size of Chronic Idiopathic Constipation (CIC) in Spain
13.2.4.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in Spain
13.2.4.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in Spain
13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.5. United Kingdom
13.2.5.1. Market Size of Chronic Idiopathic Constipation (CIC) in United Kingdom
13.2.5.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in United Kingdom
13.2.5.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in United Kingdom
13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market
13.3. Japan
13.3.1. Market Size of Chronic Idiopathic Constipation (CIC) in Japan
13.3.2. Percentage Share of drugs marketed for Chronic Idiopathic Constipation (CIC) in Japan
13.3.3. Market Sales of Chronic Idiopathic Constipation (CIC) by Products in Japan
13.3.4. Analysis of Upcoming Therapies and their Impact on the Market
14. Market Drivers
15. Market Barriers
16. Appendix
17. Report Methodology
17.1. Sources
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
Table 1: Total Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in 7MM
Table 2: Total Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Table 4: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Table 5: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Table 6: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Table 7: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Table 8: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Table 9: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Table 10: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Table 11: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Table 12: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Table 13: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Table 14: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Table 15: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Table 16: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Table 17: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Table 18: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Table 19: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Table 20: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Table 21: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Table 22: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Table 23: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Table 24: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Table 25: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Table 26: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Table 27: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Table 28: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Table 29: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Table 30: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Table 31: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Table 32: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Table 33: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Table 34: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Table 35: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Table 36: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Table 37: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Table 42:7MM- Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 43:7MM- Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 44: United States-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Table 45: United States-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 46: United States-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 47: Germany-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Table 48: Germany-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 49: Germany-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 50: France-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Table 51: France-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 52: France-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 53: Italy-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Table 54: Italy-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 55: Italy-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 56: Spain-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Table 57: Spain-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 58: Spain-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 59:UK-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Table 60:UK-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 61:UK-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 62: Japan-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Table 63: Japan-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Table 64: Japan-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 1: Total Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Figure 4: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Figure 5: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Figure 6: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Figure 7: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in United States (2017-2028)
Figure 8: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Figure 9: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Figure 10: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Figure 11: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Figure 12: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Germany (2017-2028)
Figure 13: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Figure 14: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Figure 15: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Figure 16: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Figure 17: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in France (2017-2028)
Figure 18: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Figure 19: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Figure 20: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Figure 21: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Figure 22: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Italy (2017-2028)
Figure 23: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Figure 24: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Figure 25: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Figure 26: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Figure 27: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Spain (2017-2028)
Figure 28: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Figure 29: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Figure 30: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Figure 31: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Figure 32: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in UK (2017-2028)
Figure 33: Prevalent/Incident Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Figure 34: Sub-Type Specific cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Figure 35: Sex- Specific Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Figure 36: Diagnosed Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Figure 37: Treatable Cases of the Chronic Idiopathic Constipation (CIC) in Japan (2017-2028)
Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Figure 42:7MM- Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 43:7MM- Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 44: United States-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Figure 45: United States-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 46: United States-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 47: Germany-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Figure 48: Germany-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 49: Germany-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 50: France-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Figure 51: France-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 52: France-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 53: Italy-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Figure 54: Italy-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 55: Italy-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 56: Spain-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Figure 57: Spain-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 58: Spain-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 59:UK-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Figure 60:UK-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 61:UK-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 62: Japan-Market Size of Chronic Idiopathic Constipation (CIC) in USD MM (2017-2028)
Figure 63: Japan-Market Share Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)
Figure 64: Japan-Market Sales of Chronic Idiopathic Constipation (CIC) by Therapies in USD MM (2017-2028)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report